Brigatinib
Jump to navigation
Jump to search
Brigatinib | |
---|---|
Term | Brigatinib |
Short definition | Brigatinib - (pronounced) (brih-ga-tih feather) A drug used to treat adults with non-small cell lung cancer that has spread and is ALK-positive. It is also being studied in the treatment of other types of cancer. |
Type | Cancer terms |
Specialty | Oncology |
Language | English |
Source | NCI |
Comments |
Brigatinib - (pronounced) (brih-ga-tih feather) A drug used to treat adults with non-small cell lung cancer that has spread and is ALK-positive. It is also being studied in the treatment of other types of cancer. Brigatinib blocks certain proteins made by theALKGen. Blocking these proteins can stop the growth and spread of cancer cells. Brigatinib is a type of tyrosine kinase inhibitor. Also called Alunbrig
External links
- Medical encyclopedia article on Brigatinib
- Wikipedia's article - Brigatinib
This WikiMD dictionary article is a stub. You can help make it a full article.
Languages: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski